Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium for Prevention of Atrial Arrhythmias After Cardiac Surgery
NCT00250965Phase 3Terminated
- Sponsor
- University of British Columbia
- Start
- Jul 2004
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Magnesium Sulfate with Placebo (2 arms). Primary endpoint: Incidence of Atrial Fibrillation. Started Jul 2004; status: terminated.
02
Drugs
magnesium sulfate
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00250965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00250965.